Michael S. Cuffe, EVP and Chief Clinical Officer at HCA Healthcare, Inc. (HCA), sold 7,128 shares at $306.79 ($2.0M) on 2024-01-31, disclosed to the SEC on 2024-02-02.
Seasonal sale ($2.0M) by EVP and Chief Clinical Officer — this insider has traded HCA in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 728 | $0 | 0.0% |
| 2 | $306.79 | 3,200 | $982K | 50.0% |
| 3 | $306.79 | 3,200 | $982K | 50.0% |
| Total | $275.46 avg | 7,128 | $2.0M | 100% |
| Filing → |
| HCA | SELL | 2024-09-12 | $6.4M | — | Filing → |
| HCA | SELL | 2024-05-13 | $4.0M | — | Filing → |
| HCA | SELL | 2024-05-08 | $494K | — | Filing → |